{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:52:34Z","timestamp":1772459554691,"version":"3.50.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3,1]]},"DOI":"10.1093\/infdis\/jiu548","type":"journal-article","created":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T04:37:58Z","timestamp":1412743078000},"page":"801-810","source":"Crossref","is-referenced-by-count":22,"title":["AS03B-Adjuvanted H5N1 Influenza Vaccine in Children 6 Months Through 17 Years of Age: A Phase 2\/3 Randomized, Placebo-Controlled, Observer-Blinded Trial"],"prefix":"10.1093","volume":"211","author":[{"given":"Pope","family":"Kosalaraksa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Jeanfreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Frenette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamadou","family":"Drame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Madariaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce L.","family":"Innis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Godeaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Izurieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Vaughn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,10,6]]},"reference":[{"key":"key\n\t\t\t\t20170511124536_JIU548C1","article-title":"Cumulative number of confirmed human cases of avian influenza A\/(H5N1) reported to WHO","author":"World Health Organization","year":"2014"},{"key":"key\n\t\t\t\t20170511124536_JIU548C2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/cid\/cis295","article-title":"H5N1 avian influenza in children","volume":"55","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170511124536_JIU548C3","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMoa0906695","article-title":"Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009","volume":"361","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170511124536_JIU548C4","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(09)62126-7","article-title":"Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170511124536_JIU548C5","article-title":"FDA approves first adjuvanted vaccine for prevention of H5N1 avian influenza","author":"Food and Drug Administration","year":"2013"},{"key":"key\n\t\t\t\t20170511124536_JIU548C6","article-title":"H5N1 influenza virus vaccine, manufactured by Sanofi Pasteur, Inc. Questions and answers","author":"US Food and Drug Administration","year":"2013"},{"key":"key\n\t\t\t\t20170511124536_JIU548C7","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1517\/14712590903066695","article-title":"Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data","volume":"9","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"key\n\t\t\t\t20170511124536_JIU548C8","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1086\/652701","article-title":"Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1\/2 trial in adults","volume":"201","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170511124536_JIU548C9","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/INF.0b013e3181daf921","article-title":"Immunogenicity and safety of H5N1 A\/Vietnam\/1194\/2004 (clade 1) AS03-adjuvanted pre-pandemic candidate influenza vaccines in children aged 3 to 9 years: A Phase II, randomized, open, controlled study","volume":"29","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170511124536_JIU548C10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virusres.2004.02.029","article-title":"Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use","volume":"103","year":"2004","journal-title":"Virus Res"},{"key":"key\n\t\t\t\t20170511124536_JIU548C11","first-page":"B17","volume-title":"Hemagglutination inhibition. Concepts and procedures for laboratory-based influenza surveillance","year":"1982"},{"key":"key\n\t\t\t\t20170511124536_JIU548C12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays","volume":"37","year":"1999","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170511124536_JIU548C13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2004.02.019","article-title":"Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A\/Duck\/Singapore\/97 vaccine","volume":"103","year":"2004","journal-title":"Virus Res"},{"key":"key\n\t\t\t\t20170511124536_JIU548C14","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","year":"1938","journal-title":"Am J Hyg"},{"key":"key\n\t\t\t\t20170511124536_JIU548C15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.vaccine.2003.09.007","article-title":"Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation","volume":"22","year":"2004","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170511124536_JIU548C16","article-title":"Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines","author":"Center for Biologics Evaluation and Research, Food and Drug Administration, US Department of Health and Human Services","year":"2007"},{"key":"key\n\t\t\t\t20170511124536_JIU548C17","article-title":"CHMP recommendations for the pharmacovigilance plan as part of the risk management plan to be submitted with the marketing authorisation application for a pandemic influenza vaccine","author":"European Committee for Proprietary Medicinal Products, European Medicines Agency","year":"2009"},{"key":"key\n\t\t\t\t20170511124536_JIU548C18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.vaccine.2009.10.017","article-title":"Priming with AS03(A)-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study","volume":"28","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170511124536_JIU548C19","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1016\/j.vaccine.2008.08.046","article-title":"Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children","volume":"26","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170511124536_JIU548C20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(09)62026-2","article-title":"Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170511124536_JIU548C21","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1086\/655830","article-title":"AS03(A)-Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of Age","volume":"51","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170511124536_JIU548C22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0264-410X(94)90039-6","article-title":"HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992","volume":"12","year":"1994","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170511124536_JIU548C23","doi-asserted-by":"crossref","first-page":"e1665","DOI":"10.1371\/journal.pone.0001665","article-title":"Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine","volume":"3","year":"2008","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170511124536_JIU548C24","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.vaccine.2008.02.068","article-title":"Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial","volume":"26","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170511124536_JIU548C25","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170511124536_JIU548C26","doi-asserted-by":"crossref","first-page":"f794","DOI":"10.1136\/bmj.f794","article-title":"Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis","volume":"346","year":"2013","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170511124536_JIU548C27","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/brain\/awt187","article-title":"Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France","volume":"136","year":"2013","journal-title":"Brain J Neurol"},{"key":"key\n\t\t\t\t20170511124536_JIU548C28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.sleep.2013.03.020","article-title":"Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A","volume":"14","year":"2013","journal-title":"Sleep Med"},{"key":"key\n\t\t\t\t20170511124536_JIU548C29","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1212\/WNL.0b013e31828ab26f","article-title":"Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination","volume":"80","year":"2013","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170511124536_JIU548C30","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.vaccine.2012.12.015","article-title":"The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns","volume":"31","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170511124536_JIU548C31","article-title":"Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010. Final Report of National Narcolepsy Study Steering Committee","year":"2010"},{"key":"key\n\t\t\t\t20170511124536_JIU548C32","article-title":"Narcolepsy in association with pandemic vaccination; a multi-country European epidemiological investigation","author":"European Centre for Disease Control and Prevention","year":"2012"},{"key":"key\n\t\t\t\t20170511124536_JIU548C33","article-title":"Increased risk of narcolepsy observed also among adults vaccinated with Pandemrix in Finland","author":"National Institute for Health and Welfare","year":"2013"},{"key":"key\n\t\t\t\t20170511124536_JIU548C34","article-title":"Registry study confirms increased risk of narcolepsy after vaccination with Pandemrix in children and adolescents and shows an increased risk in young adults","year":"2013"},{"key":"key\n\t\t\t\t20170511124536_JIU548C35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70","year":"2011","journal-title":"Ann Neurol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/211\/5\/801\/16867429\/jiu548.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T08:13:09Z","timestamp":1650355989000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jiu548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,6]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,10,6]]},"published-print":{"date-parts":[[2015,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiu548","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,6]]}}}